Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Clinical trial NCT00535288 · COMPLETED

Trial details

NCT number: NCT00535288
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Symptoms Menopause Vasomotor Symptoms

Start date: 2004-09-15
Primary completion: 2006-01-15
Enrollment: 946

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.